Budget Impact of the Introduction of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir, the First Integrase Inhibitor-Based Single Tablet Antiretroviral Regimen for HIV Treatment, to Third Party Payers in the United States

Abstract

A343diseases, age at first pap smear, pap smear frequency, use of oral contraceptives and the number of pregnancies. Results: Overall, 600 respondents were eligible for the analysis, consisting of 465 patients (44.0±16.3 years) and 135 controls (44.0±13.2 years). More than 5 sexual partners increased the risk of acquiring HPV infections up to 2.52-fold (95%CI: 1.34-4.74), while smoking or an early sexual debut (≤ 18 years) raised it by about a factor of 1.62. Higher levels of education were associated with a protective effect. The overall rate of individuals at high risk with more than 5 sexual partners and at least another additional factor corresponded to 26.3% (158 out of 600). The proportion of subjects with an average risk (respondents with less than 5 partners and at least another additional factor) amounted to 53.2% (319 out of 600). ConClusions: Analysis of risk factors can be used as part of the economic assessment of other effective HPV vaccination strategies, including an immunization programme for pre-adolescents of both sexes in Italy. PIN16A Study of A.